- Home
- PKE vs FDMT Comparison
PKE vs FDMT Comparison
Compare PKE & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKE
- FDMT
- Stock Information
- Founded
- PKE 1954
- FDMT 2013
- Country
- PKE United States
- FDMT United States
- Employees
- PKE N/A
- FDMT N/A
- Industry
- PKE Military/Government/Technical
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- PKE Industrials
- FDMT Health Care
- Exchange
- PKE Nasdaq
- FDMT Nasdaq
- Market Cap
- PKE 378.7M
- FDMT 391.8M
- IPO Year
- PKE N/A
- FDMT 2020
- Fundamental
- Price
- PKE $20.93
- FDMT $9.96
- Analyst Decision
- PKE
- FDMT Strong Buy
- Analyst Count
- PKE 0
- FDMT 8
- Target Price
- PKE N/A
- FDMT $30.63
- AVG Volume (30 Days)
- PKE 176.1K
- FDMT 775.9K
- Earning Date
- PKE 10-09-2025
- FDMT 11-12-2025
- Dividend Yield
- PKE 2.39%
- FDMT N/A
- EPS Growth
- PKE 5.81
- FDMT N/A
- EPS
- PKE 0.36
- FDMT N/A
- Revenue
- PKE $63,128,000.00
- FDMT $33,000.00
- Revenue This Year
- PKE N/A
- FDMT $9,656.76
- Revenue Next Year
- PKE N/A
- FDMT N/A
- P/E Ratio
- PKE $58.79
- FDMT N/A
- Revenue Growth
- PKE 7.63
- FDMT N/A
- 52 Week Low
- PKE $11.97
- FDMT $2.24
- 52 Week High
- PKE $21.52
- FDMT $10.26
- Technical
- Relative Strength Index (RSI)
- PKE 59.57
- FDMT 70.30
- Support Level
- PKE $19.53
- FDMT $8.50
- Resistance Level
- PKE $21.50
- FDMT $10.03
- Average True Range (ATR)
- PKE 0.98
- FDMT 0.65
- MACD
- PKE 0.04
- FDMT 0.08
- Stochastic Oscillator
- PKE 74.81
- FDMT 87.33
About PKE Park Aerospace Corp.
Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.